HealthStacy M. Brown

Top Infectious Disease Doctors Contradict Trump’s Vaccine Promise

Contradicting medical science experts and ignoring that a British company was forced to suspend its work on COVID-19 clinical trials, President Donald Trump maintains that America will have a vaccine ready by Nov. 1, just ahead of the 2020 election.

“I think we can probably have it sometime in October,” Trump declared.

But that declaration seems more and more destined to have the label of an empty campaign promise from the nation’s 45th president.

“No. Absolutely not,” said Dr. James E.K. Hildreth, one of the world’s foremost immunologist, and president and CEO of Meharry Medical College in Nashville, Tennessee.

“There is no way any of the vaccines currently being studied can be proven safe and effective by Nov. 1,” exclaimed Dr. Hildreth, a recent appointee to the U.S. Food and Drug Administration’s commission that would ultimately approve vaccines.

“There’s no way that I’m going to approve a vaccine that hasn’t met all of the safety criteria,” Dr. Hildreth continued.

“The Phase 3 trial, which is the next to last phase, is the largest by far with tens of thousands of people being enrolled. We have to get 30,000 people per vaccine, which means the prospect of enrolling 30,000 people and watching them long enough to see who gets infected and who doesn’t, can’t happen in two months. As far as I’m concerned, any vaccine promise by Nov. 1 should be summarily dismissed. I would certainly not take a vaccine that came online on Nov. 1.”

Trials of a COVID-19 vaccine under development by Oxford University and the pharmaceutical company AstraZeneca was halted after one patient fell ill. Officials said that the study had reached its late stages when the unidentified patient suffered “a potentially unexplained illness.”

It’s believed that the British government has spent billions on clinical trials. The Trump administration has announced vaccine-related deals that total more than $10 billion despite no guarantees of effectiveness or that any successful vaccine would hit the market affordably.

“It’s very unlikely that we would green-light a vaccine by early November because data from late-stage clinical trials of leading vaccine candidates would not be ready by then,” said Moncef Slaoui, the head of the federal government’s vaccine accelerator.

Dr. Anthony Fauci, an immunologist and director of the National Institute of Allergy and Infectious Diseases, also threw shade at Trump’s Nov.1 promise.

“If you look at the projection of the enrollment and the kinds of things, you’ll need to get a decision about whether the vaccine is safe and effective, most of us project that’s going to be by November and December, by the end of this year,” Dr. Fauci stated. “It is conceivable that you could have it by October, though I don’t think that that’s likely.”

Dr. Hildreth also noted the “horror” stories of what has happened to African Americans’ bodies during prior research trials.

He pointed out that any vaccine must have the confidence of Black people.

“I believe if we have more African American physicians and scientists, we will have more African American participation [in clinical trials,” Dr. Hildreth stated. This month, Bloomberg Philanthropies provided Meharry Medical College with a $34 million grant to help attract more African American physicians.

“I’ve made the decision that I’m going to participate in one of the vaccine trials,” Dr. Hildreth said. “The trust issue cannot be overstated. We have to have more trusted messengers and more trusted opinion leaders to make this work.”

He warned that an approved vaccine might not be for everyone.

“If you have compromised immune system, it’s not likely that you will be allowed to participate in a vaccine study because the vaccine itself might do you harm,” Dr. Hildreth warned. “Certain cancer patients are not likely to participate because some cancers in it of themselves compromise the immune system. Some vaccines might interfere with cancer treatment, so it would not be advisable.”

Tags
Show More

Stacy M. Brown

I’ve worked for the Daily News of Los Angeles, the L.A. Times, Gannet and the Times-Tribune and have contributed to the Pocono Record, the New York Post and the New York Times. Television news opportunities have included: NBC, MSNBC, Scarborough Country, the Abrams Report, Today, Good Morning America, NBC Nightly News, Imus in the Morning and Anderson Cooper 360. Radio programs like the Wendy Williams Experience, Tom Joyner Morning Show and the Howard Stern Show have also provided me the chance to share my views.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker